Accessing target information by virtual parallel screening-The impact on natural product research

Phytochemistry Letters

Volumn 2, Issue 2, 2009, Pages 53-58

  Rollinger, Judith M ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Docking; Drug discovery; Multi target drugs; Pharmacophore based virtual screening; Target fishing

Indexed keywords

NATURAL PRODUCT; RUTA GRAVEOLENS EXTRACT;

ACCESS TO INFORMATION; COMPUTER MODEL; COMPUTER PROGRAM; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG RESEARCH; DRUG TARGETING; EXPERIMENTAL STUDY; MOLECULAR MECHANICS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; THREE DIMENSIONAL IMAGING; VIRTUAL REALITY;

EID: 63049086100     PISSN: 18743900     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytol.2008.12.002     Document Type: Review

References (34)

1. Berman H., Westbrook J., Feng Z., Gilliland G., Bhat T., Weissig H., Shindyalov I., and Bourne P. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
2. Brown D., and Superti-Furga G. Rediscovering the sweet spot in drug discovery. Drug Discov. Today 8 (2003) 1067-1077
3. Do Q.-T., Renimel I., Andre P., Lugnier C., Muller C.D., and Bernard P. Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of ε-viniferin. Curr. Drug Disc. Technol. 2 (2005) 161-167
4. Do Q.-T., Lamy C., Renimel I., Sauvan N., Andre P., Himbert F., Morin-Allory L., and Bernard P. Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin. Planta Med. 73 (2007) 1235-1240
5. Güner O.F. The impact of pharmacophore modeling in drug design. Drugs 7 (2005) 567-572
6. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Disc. Today 5 (2000) 294-300
7. Hopkins A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4 (2008) 682-690
8. Jiang X., Kumar K., Hu X., Wallqvist A., and Reifman J. DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chem. Centr. J. 2 (2008) 18
9. Khedar S.A., Malde A.K., Coutinho E.C., and Srivastava S. Pharmacophore modeling in drug discovery and development: an overview. Med. Chem. 2 (2007) 187-197
10. Kirchmair J., Markt P., Distinto S., Schuster D., Spitzer G., Liedl K., Laggner C., Langer T., and Wolber G. The Protein Data Bank (PDB), its related services and software tools as key components for in-silico guided drug discovery. J. Med. Chem. 51 (2008) 7021-7040
11. Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug Disc. Today 11 (2006) 580-594
12. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3 (2004) 711-716
13. Korcsmaros T., Szalay M.S., Bode C., Kovacs I.A., and Csermely P. How to design multi-target drugs: target search options in cellular networks. Expert Opin. Drug Discov. 2 (2007) 799-808
14. Krovat E.M., Steindl T., and Langer T. Recent advances in docking and scoring. Curr. Comput. Aided Drug Des. 1 (2005) 93-102
15. Langer T., and Hoffmann R.D. Pharmacophore modelling: applications in drug discovery. Expert Opin. Drug Disc. 1 (2006) 261-267
16. Markt P., Schuster D., Kirchmair J., Laggner C., and Langer T. Pharmacophore modeling and parallel screening for PPAR ligands. J. Comput. Aided Mol. Des. 21 (2007) 575-590
17. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70 (2007) 461-477
18. Paul N., Kellenberger E., Bret G., Mueller P., and Rognan D. Recovering the true targets of specific ligands by virtual screening of the Protein Data Bank. Proteins 54 (2004) 671-680
19. Rognan D. In silico screening of the protein structure repertoire and of protein families. Chemogenomics (2006) 109-131
20. Rollinger J.M., Langer T., and Stuppner H. Strategies for efficient lead structure discovery from natural products. Curr. Med. Chem. 13 (2006) 1491-1507
21. Rollinger J.M., Langer T., and Stuppner H. Integrated in silico tools to exploit the natural products' bioactivity. Planta Med. 72 (2006) 671-678
22. Rollinger J.M., Stuppner H., and Langer T. Virtual screening for the discovery of bioactive natural products. In: Petersen F., and Amstutz R. (Eds). Natural Compounds as Drugs, vol. I (2008), Birkhäuser Verlag, Basel, Switzerland 212-249
23. Rollinger, J.M., Schuster, D., Danzl, B., Schwaiger, S., Markt, P., Schmidtke, M., Gertsch, J., Radurner, S., Wolber, G., Langer, T., Stuppner, H., in press. In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens L. Planta Med.
24. Schneider G., and Böhm H.J. Virtual screening and fast automated docking methods. Drug Disc. Today 7 (2002) 64-70
25. Shave S.R., Taylor P., Walkinshaw M., Smith L., Hardy J., and Trew A. Ligand discovery on massively parallel systems. IBM J. Res. Dev. 52 (2008) 57-67
26. Shoichet B.K., McGovern S.L., Wei B., and Irwin J.J. Lead discovery using molecular docking. Curr. Opin. Chem. Biol. 6 (2002) 439-446
27. Steindl T.M., Schuster D., Laggner C., and Langer T. Parallel screening: a novel concept in pharmacophore modelling and virtual screening. J. Chem. Inf. Model. 46 (2006) 2146-2157
28. Steindl T.M., Schuster D., Wolber G., Laggner C., and Langer T. High throughput structure-based pharmacophore modeling as a basis for successful parallel virtual screening. J. Comput. Aided Mol. Des. 20 (2006) 703-715
29. Steindl T.M., Schuster D., Laggner C., Chuang K., Hoffmann R., and Langer T. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models. J. Chem. Inf. Model. 47 (2007) 563-571
30. Strohl W.R. The role of natural products in a modern drug discovery program. Drug Disc. Today 5 (2000) 39-41
31. Taylor P., Blackburn E., Sheng Y.G., Harding S., Hsin K.-Y., Kan D., Shave S., and Walkinshaw M.D. Ligand discovery and virtual screening using the program LIDAEUS. Br. J. Pharmacol. 153 Suppl. 1 (2008) S55-S67
32. Williams D.H., Stone M.J., Hauck P.R., and Rahman S.K. Why are secondary metabolites (natural products) synthesized?. J. Nat. Prod. 52 (1989) 1198-1208
33. Wolber G., and Langer T. LigandScout: 3D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 45 (2005) 160-169
34. Zhang S., Kumar K., Jiang X., Wallqvist A., and Reifman J. DOVIS: an implementation for high-throughput virtual screening using AutoDock. BMC Bioinformatics 9 (2008) 126